Recent studies have shown that SNHG7 acts as an oncogene, and its expression significantly increased in a wide range of carcinomas, including pancreatic cancer, thyroid cancer, bladder cancer, breast cancer, cervical cancer, gastric cancer, hepatocellular carcinoma, hypopharyngeal cancer, melanoma, and neuroblastoma [19]. This evidence concerns the gene SNHG7 and hypopharynx cancer.